| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |